Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022

SELL
$4.99 - $7.46 $276,675 - $413,627
-55,446 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$7.16 - $9.69 $396,993 - $537,271
55,446 New
55,446 $397,000
Q1 2021

May 14, 2021

SELL
$8.81 - $16.96 $493,923 - $950,845
-56,064 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$8.5 - $12.85 $476,544 - $720,422
56,064 New
56,064 $496,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $499M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.